Addex Therapeutics Correlations
| ADXN Stock | USD 8.37 0.54 6.90% |
The current 90-days correlation between Addex Therapeutics and Aptorum Group Ltd is 0.01 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Addex Therapeutics Correlation With Market
Significant diversification
The correlation between Addex Therapeutics and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Addex Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving against Addex Stock
| 0.64 | MBRX | Moleculin Biotech | PairCorr |
| 0.6 | VALN | Valneva SE ADR Upward Rally | PairCorr |
| 0.46 | EQ | Equillium | PairCorr |
| 0.48 | MNKD | MannKind Corp | PairCorr |
| 0.43 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.41 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.39 | DRMA | Dermata Therapeutics | PairCorr |
| 0.37 | DTIL | Precision BioSciences | PairCorr |
| 0.49 | MOLN | Molecular Partners | PairCorr |
| 0.44 | MNOV | MediciNova | PairCorr |
| 0.41 | VINC | Vincerx Pharma, Common | PairCorr |
| 0.34 | MRSN | Mersana Therapeutics | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Addex Stock performing well and Addex Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Addex Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| APM | 5.94 | 1.53 | 0.32 | 1.07 | 4.32 | 8.70 | 118.27 | |||
| SRZN | 3.47 | 0.16 | 0.00 | 0.05 | 0.00 | 7.48 | 26.79 | |||
| UNCY | 5.75 | (0.29) | 0.00 | (0.05) | 0.00 | 14.48 | 60.25 | |||
| ARMP | 5.10 | 1.11 | 0.21 | 1.13 | 4.78 | 8.51 | 86.51 | |||
| REVB | 4.74 | (1.13) | 0.00 | (25.93) | 0.00 | 9.33 | 61.31 | |||
| DRMA | 3.15 | (0.09) | (0.04) | 0.06 | 3.31 | 8.47 | 22.00 | |||
| AFIB | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Addex Therapeutics Corporate Management
| Timothy Dyer | CEO CoFounder | Profile | |
| Werner Henrichi | Consultant | Profile | |
| Mikhail Kalinichev | Head Science | Profile | |
| JeanPhilippe Rocher | Head Chemistry | Profile | |
| Roger MD | Chief Director | Profile | |
| Lnaic Teyssdou | Head Finance | Profile | |
| Robert Lutjens | Head Biology | Profile |